A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
Clinical trial NCT02207244 · COMPLETED
Trial details
- NCT number
- NCT02207244
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-03
- Primary completion
- 2015-10-01
- Enrollment
- 992
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.